Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles

Journal of Virology

Volumn 77, Issue 19, 2003, Pages 10548-10556

  Schindler, Michael ^a   Würfl, Stephanie ^a   Benaroch, Philippe ^b   Greenough, Thomas C ^c   Daniels, Rod ^d   Easterbrook, Philippa ^e   Brenner, Matthias ^a   Münch, Jan ^a   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b INSTITUT CURIE   (France)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN II; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ANTIGEN PRESENTATION; ARTICLE; ASSAY; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IN VITRO STUDY; LENTIVIRINAE; MUTATIONAL ANALYSIS; NEF GENE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; UPREGULATION; VIRUS GENE; VIRUS STRAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; AMINO ACID SEQUENCE; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; DOWN-REGULATION; GENE PRODUCTS, NEF; GENES, NEF; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; SIMIAN IMMUNODEFICIENCY VIRUS; UP-REGULATION;

EID: 0141521574     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.19.10548-10556.2003     Document Type: Article

References (67)

1. Aiken, C., J. Konner, N. R. Landau, M. E. Lenburg, and D. Trono. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864.
2. Alexander, L., E. Weiskopf, T. C. Greenough, N. C. Gaddis, M. R. Auerbach, M. H. Malim, S. J. O'Brien, B. D. Walker, J. L. Sullivan, and R. C. Desrosiers. 2000. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J. Virol. 74:4361-4376.
3. Alexander, L., Z. Du, A. Y. Howe, S. Czajak, and R. C. Desrosiers. 1999. Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1. J. Virol. 73:5814-5825.
4. Alexander, L., Z. Du, M. Rosenzweig, J. U. Jung, and R. C. Desrosiers. 1997. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J. Virol. 71:6094-6099.
5. Bell, I., C. Ashman, J. Maughan, E. Hooker, F. Cook, and T. A. Reinhart. 1998. Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) zeta chain leads to TCR down-modulation. J. Gen. Virol. 79:2717-2727.
6. + T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991.
7. + T cells. Crit. Rev. Immunol. 16:359.
8. Carl, S., T. C. Greenough, M. Krumbiegel, M. Greenberg, J. Skowronski, J. L. Sullivan, and F. Kirchhoff. 2001. Modulation of different human immunodeficiency virus type 1. Nef functions during progression to AIDS. J. Virol. 75:3657-3665.
9. Chowers, M. Y., C. A. Spina, T. J. Kwoh, N. J. Fitch, D. D. Richman, and J. C. Guatelli. 1994. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68:2906-2914.
10. Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10:661-671.
11. Collins, K. L., B. K. Chen, S. A. Kalams, B. D. Walker, and D. Baltimore. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401.
12. Craig, H. M., M. W. Pandori, and J. C. Guatelli. 1998. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc. Natl. Acad. Sci. USA 95:11229-11234.
13. Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505-507.
14. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, and C. Chatfield. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
15. Dyer, W. B., G. S. Ogg, M. A. Demoitie, X. Jin, A. F. Geczy, S. L. Rowland-Jones, A. J. McMichael, D. F. Nixon, and J. S. Sullivan. 1999. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J. Virol. 73:436-443.
16. Dyer, W. B., A. F. Geczy, S. J. Kent, L. B. McIntyre, S. A. Blasdall, J. C. Learmont, and J. S. Sullivan. 1997. Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. AIDS 11:1565-1574.
17. Easterbrook, P. J., T. Rostron, N. Ives, M. Troop, B. G. Gazzard, and S. L. Rowland-Jones. 1999. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. J. Infect. Dis. 180:1096-1105.
18. Garcia, J. V., and A. D. Miller. 1991. Serine phosphorylation-independent down-regulation of cell-surface CD4 by nef. Nature 350:508-519.
19. Gauduin, M. C., R. L. Glickman, S. Ahmad, T. Yilma, and R. P. Johnson. 1999. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production. Proc. Natl. Acad. Sci. USA 96:14031-14036.
20. Geyer, M., O. T. Fackler, and B. M. Peterlin. 2001. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2:580-585.
21. Gibbs, J. S., A. A. Lackner, S. M. Lang, M. A. Simon, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1995. Progression to AIDS in the absence of genes for vpr or vpx. J. Virol. 69:2378-2383.
22. Grakoui, A., S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 1999. The immunological synapse: a molecular machine controlling T-cell activation. Science 285:221-227.
23. Greenberg, M. E., A. J. Iafrate, and J. Skowronski. 1998. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17:2777-2789.
24. Greenough, T. C., D. B. Brettler, F. Kirchhoff, L. Alexander, R. C. Desrosiers, S. J. O'Brien, M. Somasundaran, K. Luzuriaga, and J. L. Sullivan. 1999. Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort. J. Infect. Dis. 180:1790-1802.
25. Greenough, T. C., M. Somasundaran, D. B. Brettler, R. M. Hesselton, A. Alimenti, F. Kirchhoff, D. Panicali, and J. L. Sullivan. 1994. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus infection. AIDS Res. Hum. Retrovir. 10:395-403.
26. Hanna, Z., D. G. Kay, N. Rebai, A. Guimond, S. Jothy, and P. Jolicoeur. 1998. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95:163-175.
27. Hiebenthal-Millow, K., and F. Kirchhoff. 2002. The most frequent naturally occurring length polymorphism in the HIV-1 LTR has little effect on proviral transcription and viral replication. Virology 292:169-175.
28. Howe, A. Y., J. U. Jung, and R. C. Desrosiers. 1998. ζ chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J. Virol. 72:9827-9834.
29. Hwang, I., J.-F. Huang, H. Kishimoto, A. Brunmark, P. A. Peterson, M. R. Jackson, C. D. Surh, Z. Cai, and J. Sprent. 2000. T cells can use either T-cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen presenting cells. J. Exp. Med. 191:1137-1148.
30. Iafrate, A. J., S. Carl, S. Bronson, C. Stahl-Hennig, T. Swigut, J. Skowronski, and F. Kirchhoff. 2000. Disrupting surfaces of Nef required for down-regulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo. J. Virol. 74:9836-9844.
31. Iafrate, A. J., S. Bronson, and J. Skowronski. 1997. Separable functions of Nef disrupt two aspects of T-cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16:673-684.
32. Johnson, W. E., and R. C. Desrosiers. 2002. Viral persistance: HIV's strategies of immune system evasion. Annu. Rev. Med. 53:499-518.
33. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Munoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D. L. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-411.
34. Kasper, M. R., and K. L. Collins. 2003. Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. J. Virol. 77:3041-3049.
35. Kestler, H. W., T. Kodama, D. J. Ringler, M. Marthas, N. Pedersen, A. Lackner, D. Regier, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
36. Kestler, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
37. Kirchhoff, F., J. Munch, S. Carl, N. Stolte, K. Matz-Rensing, D. Fuchs, P. T. Haaft, J. L. Heeney, T. Swigut, J. Skowronski, and C. Stahl-Hennig. 1999. The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo. J. Virol. 73:8371-8383.
38. Kirchhoff, F., K. D. Jentsch, A. Stuke, J. Mous, and G. Hunsmann. 1990. Genomic divergence of an HIV-2 from a German AIDS patient probably infected in Mali. AIDS 4:847-857.
39. Kirchhoff, F., P. J. Easterbrook, N. Douglas, M. Troop, T. C. Greenough, J. Weber, S. Carl, J. L. Sullivan, and R. S. Daniels. 1999. Sequence variations in human immunodeficiency virus type 1 Nef are associated with a different stages of disease. J. Virol. 73:5497-5508.
40. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Absence of intact nef sequences in a long-term, nonprogressing survivor of HIV-1 infection. N. Engl. J. Med. 332:228-232.
41. Learmont, J. C., A. F. Geczy, J. Mills, L. J. Ashton, C. H. Raynes-Greenow, R. J. Garsia, W. B. Dyer, L. McIntyre, R. B. Oelrichs, D. I. Rhodes, N. J. Deacon, and J. S. Sullivan. 1999. Immunological and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. N. Engl. J. Med. 340:1715-1722.
42. Le Gall, S., M. C. Prevost, J. M. Heard, and O. Schwartz. 1997. Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity. Virology 229:295-301.
43. Mariani, R., F. Kirchhoff, T. C. Greenough, J. L. Sullivan, R. C. Desrosiers, and J. Skowronski. 1996. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J. Virol. 70:7752-7764.
44. Miller, M. D., M. T. Warmerdam, I. Gaston, W. C. Greene, and M. B. Feinberg. 1994. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:101-114.
45. Münch, J., N. Stolte, D. Fuchs, C. Stahl-Hennig, and F. Kirchhoff. 2001. Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques. J. Virol. 75:10532-10536.
46. Münch, J., A. Janardhan, N. Stolte, C. Stahl-Hennig, P. Ten Haaft, J. L. Heeney, T. Swigut, F. Kirchhoff, and J. Skowronski. 2002. T-cell receptor: CD3 down-regulation is a selected in vivo function of simian immunodeficiency virus Nef but is not sufficient for effective viral replication in rhesus macaques. J. Virol. 76:12360-12364.
47. Patel, P. G., M. T. Yu Kimata, J. E. Biggins, J. M. Wilson, and J. T. Kimata. 2002. Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens. J. Virol. 76:6425-6434.
48. Pieters, J. 2000. MHC class II-restricted antigen processing and presentation. Adv. Immunol. 75:159-208.
49. Regier, D. A., and R. C. Desrosiers. 1989. The complete nucleotide sequence of a pathogenic molecular clone of SIV. AIDS Res. Hum. Retrovir. 6:1221-1231.
50. Renkema, G. H., and K. Saksela. 2000. Interactions of HIV-1 NEF with cellular signal transducing proteins. Front. Biosci. 5:268-283.
51. Renkema, G. H., A. Manninen, D. A. Mann, M. Harris, and K. Saksela. 1999. Identification of the Nef-associated kinase as p21-activated kinase 2. Curr. Biol. 9:1407-1410.
52. Roche, P. A., C. L. Teletski, D. R. Karp, V. Pinet, O. Bakke, and E. O. Long. 1992. Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J. 11:2841-2847.
53. + T cell responses associated with control of viremia. Science 278:1447-1450.
54. - phenotype in HIV-1 and HIV-2. Virology 213:158-168.
55. + viruses but not for down-regulation of CD4. EMBO J. 14:484-491.
56. Schaefer, T. M., I. Bell, B. A. Fallert, and T. A. Reinhart. 2000. The T-cell receptor ζ chain contains two homologous domains with which simian immunodeficiency virus Nef interacts and mediates down-modulation. J. Virol. 74:3273-3283.
57. Schrager, J. A., and J. W. Marsh. 1999. HIV-1 Nef increases T-cell activation in a stimulus-dependent manner. Proc. Natl. Acad. Sci. USA 96:8167-8172.
58. Schwartz, O., V. Marechal, S. Le Gall, F. Lemonnier, and J. M. Heard. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-342.
59. Sievers, E., J. Neumann, M. Raftery, G. Schonrich, A. M. Eis-Hubinger, and N. Koch. 2002. Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II. Immunology 107:129-135.
60. Simmons, A., V. Aluvihare, and A. McMichael. 2001. Nef triggers a transcriptional program in T cells imitating single-signal T-cell activation and inducing HIV virulence mediators. Immunity 14:763-777.
61. Spina, C. A., T. J. Kwoh, M. Y. Chowers, J. C Guatelli, and D. D. Richman. 1994. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179:115-123.
62. Stumptner-Cuvelette, P., S. Morchoisne, M. Dugast, S. Le Gall, G. Raposo, O. Schwartz, and P. Benaroch. 2001. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. USA 98:12144-12149.
63. Stumptner-Cuvelette, P., and P. Benaroch P. 2002. Multiple roles of the invariant chain in MHC class II function. Biochim. Biophys. Acta 1542:1-13.
64. Swigut, T., A. J. Iafrate, J. Münch, F. Kirchhoff, and J. Skowronski. 2000. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility antigen expression. J. Virol. 74:5691-5701.
65. Swigut, T., N. Shody, and J. Skowronski. 2001. Mechanism for down-regulation of CD28 by Nef. EMBO J. 20:1593-1604.
66. Yamada, T., N. Kaji, T. Odawara, J. Chiba, A. Iwamoto, and Y. Kitamura. 2003. Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen. J. Virol. 77:1589-1594.
67. Zhang, B., P. Li, E. Wang, Z. Brahmi, K. W. Dunn, J. S. Blum, and A. Roman. 2003. The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology 310:100-108.